Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Brain Cancer, Blood Cancer, Infectious Disease, Lymphoma, Women's Studies, Hematology, Diabetes |
| Therapuetic Areas: | Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/13/2015 |
| Start Date: | December 2012 |
Use of a Computer-Guided Glucose Management System for Patients Undergoing Blood and Marrow Transplants (BMT)
This clinical trial studies computer-guided glucose management systems in treating patients
with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided
glucose management system may help manage glucose levels in patients who have undergone
blood or bone marrow transplant.
with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided
glucose management system may help manage glucose levels in patients who have undergone
blood or bone marrow transplant.
PRIMARY OBJECTIVES:
I. To examine the ability of computer-guided glucose management system (CGGMS) algorithms to
control glucose within or close to current University of Washington Medical Center (UWMC)
intensive care unit (ICU) targets (100 to 140 mg/dl) in non-critically ill bone marrow
transplant (BMT) adult (age >= 18 years) patients.
OUTLINE:
Patients receive blood glucose management with intravenous (IV) insulin using Glucommander.
I. To examine the ability of computer-guided glucose management system (CGGMS) algorithms to
control glucose within or close to current University of Washington Medical Center (UWMC)
intensive care unit (ICU) targets (100 to 140 mg/dl) in non-critically ill bone marrow
transplant (BMT) adult (age >= 18 years) patients.
OUTLINE:
Patients receive blood glucose management with intravenous (IV) insulin using Glucommander.
Inclusion Criteria:
- Post-transplant adult patients (age >= 18 years) on the BMT Service at UWMC
- Requiring insulin secondary to:
- Known history of (h/o) type 2 diabetes mellitus
- Two blood sugar values > 180 (point of care and/or am lab glycemia)
- One blood sugar value > 250 (point of care or AM lab glycemia)
Exclusion Criteria:
- Critically ill patients (intensive care unit [ICU] admissions)
- Terminally ill patients
- Eastern Cooperative Oncology Group (ECOG) performance status > 3
- Previous type 1 diabetes mellitus
- Cognitively impaired patients, unable to consent
We found this trial at
2
sites
Massachusetts General Hospital Cancer Center An integral part of one of the world
Click here to add this to my saved trials
1100 Fairview Avenue North
Seattle, Washington 98109
Seattle, Washington 98109
206-667-4584
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium The Fred Hutchinson/University of Washington Cancer...
Click here to add this to my saved trials